Remove Electronics Remove Leads Remove Patients Remove Side effects
article thumbnail

AI-Designed Custom Knee Implants

Medgadget

Scientists at the University of Birmingham in the UK have trialed Generative Design, a design approach that relies on machine learning and artificial intelligence, to create patient-specific knee implants. They then used an electron beam powder bed fusion to manufacture their designs.

article thumbnail

Bridging the healthcare digital divide: a gradual approach to adopting ePI

European Pharmaceutical Review

Within the EU, patient information leaflets (PILs) are not merely a regulatory requirement but a cornerstone of patient safety. They detail the medication’s intended use, proper administration, potential side effects and precautions. percent as EU average with some Member States as high as 25 percent).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Evolution of ePROM: Advancements, Concerns, and the Way Forward

PM360

Patients’ directly reported outcomes in certain rare and chronic diseases are considered reliable for understanding the disease’s natural history, palliative treatments that focus primarily on symptom control, and quality of life. 2 For example, in a study by Scripps, ePROMs positively impacted patients’ quality of life in 61.5%

article thumbnail

How Real-World Data Can Contribute to Improved Mental Health Treatment

PM360

Carl Marci, Chief Psychiatrist and Managing Director of Mental Health and Neuroscience at OM1 , about how the company is using its Mental Health and Neuroscience Real-World Data Network to help improve personalized treatment for mental health patients and increase awareness about issues related to mental health disorders.

article thumbnail

How using AI in clinical trials accelerates drug development

Pharmaceutical Technology

Clinical trials are divided into phases evaluating drug safety, side effects and effectiveness from increasingly larger pools of candidates and patients. Algorithms can also predict the toxicity of a compound and its potential side effects, allowing researchers to focus their efforts on the most promising candidates.

article thumbnail

Two Key Questions About Adherence/Compliance in 2022

PM360

The industry has been limited in its ability to implement creative solutions to engage and motivate patients because the FDA has strict guidelines for what pharma companies can communicate with patients. Today, we still can’t easily discern whether a patient took their pill or not and the reason why. Michael Oleksiw.

Medical 105
article thumbnail

Understanding the evidence used in drug product withdrawals

European Pharmaceutical Review

They also include many of the common “exclusions” in RCTs, such as pregnant women, children, the elderly and patients on multiple medications. million patients were registered with GP practices in England, which hold health information about each person “from the cradle to the grave”. As of October 2023, 62.93

Safety 111